Al-Madhoun AS

Anders Larsson

Carlander D

Chang ZF

Di RF

Dobrovolsky VN

Fujiwaki R

Gowda A

Henrik Lindman

Hu CM

Käpyaho K

Larsson A

Lena Carlsson

Madewell BR

Munch-Petersen B

O'Neill KL

Peto R

Roehl HH

Rosén M

Schwartz MK

Wu C

Zhang J

Upsala Journal of Medical Sciences

English

PubMed

Crossref

Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer

Avian antibodies can eliminate interference due to complement activation in ELISA.

Cancer incidence in ﬁve continents. Volume VIII.

Chicken antibodies: a tool to avoid interference by human anti-mouse antibodies n ELISA after in vivo treatment with murine menoclonal antibodies.

Chicken IgY: utilizing the evolutionary difference. Comp Immunol Microbiol Infect Dis.

Clinical value of thymidine kinase in patients with cervical carcinoma.

Different regulation of the human thymidine kinase promotor in normal human diploid IMR-90 ﬁbroblasts and HeLa cells.

Effect of complement binding on a solid-phase immunometric TSH essay.

Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clin Chim Acta.

Human thymidine kinase 1. Regulation in normal and malignant cells. Adv Enzyme Regul.

Identiﬁcation of a G1-S-phaseregulated region in the human thymidine kinase gene promotor. Mol Cell Biol.

Incidens och do ¨dlighet i bro ¨stcancer under 25 a ˚r. Internationella och regionala ja ¨mfo ¨relser. La ¨kartidningen. 2000;97:294 9. Thymidine kinase 1 and breast cancer 11914. Peto

Mice deﬁcient for cytosolic thymidine kinase gene develop fatal kidney disease. Mol Genet Metab.

Mitotic control of dTTP pool: a necessity or coincidence?

Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1. J Immunol Methods.

Regulation of thymidine kinase synthesis in human cells. Exp Cell Res.

Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with ﬂudarabine. Ann Oncol.

Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.

Statistics Health and Diseases 2003:6, Cancer incidence in Sweden.

The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Mini Rev Med Chem.

Thymidine kinase 1: a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients. Oncol Rep.

Thymidine kinase 1*a prognostic and diagnostic indicator in ALL and AML patients.

Use of chicken antibodies in enzyme immunoassays to avoid interference by rheumatoid factors. Clin Chem.

Use of prognostic factors in risk stratiﬁcation at diagnosis and time of treatment of patients with chronic lymphocytic leukemia. Curr Opin Hematol.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2852757

Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer

Abstract

Similar works

Full text

Available Versions

Crossref